An Antiviral Role for TRIM14 in Ebola Virus Infection

Author:

Kuroda Makoto1,Halfmann Peter J1,Thackray Larissa B2,Diamond Michael S23456,Feldmann Heinz7ORCID,Marzi Andrea7ORCID,Kawaoka Yoshihiro18910

Affiliation:

1. Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison , Madison, Wisconsin , USA

2. Department of Medicine, Washington University School of Medicine , St Louis, Missouri , USA

3. Department of Pathology and Immunology, Washington University School of Medicine , St Louis, Missouri , USA

4. Department of Molecular Microbiology, Washington University School of Medicine , St Louis, Missouri , USA

5. The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine , St Louis, Missouri , USA

6. Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine , St Louis, Missouri , USA

7. Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Hamilton, Montana , USA

8. Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo , Tokyo , Japan

9. The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute , Tokyo , Japan

10. Pandemic Preparedness, Infection and Advanced Research Center, University of Tokyo , Tokyo , Japan

Abstract

Abstract Ebola virus (EBOV) is a highly pathogenic virus that encodes 7 multifunctional structural proteins. Multiple host factors have been reported to interact with the EBOV proteins. Here, we found that tripartite motif-containing 14 (TRIM14), an interferon-stimulated gene that mediates cellular signaling pathways associated with type I interferon and inflammatory cytokine production, interacts with EBOV nucleoprotein to enhance interferon-β (IFN-β) and nuclear factor-κB (NF-κB) promotor activation. Moreover, TRIM14 overexpression reduced viral replication in an infectious but biologically contained EBOVΔVP30 system by approximately 10-fold without affecting viral protein expression. Furthermore, TRM14-deficient mice were more susceptible to mouse-adapted EBOV infection than wild-type mice. Our data suggest that TRIM14 is a host factor with anti-EBOV activity that limits EBOV pathogenesis.

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Reference35 articles.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3